Emtricitabine (Emtriva) is a first choice HIV antiretroviral (ARV) used in combination with other HIV ARVs for the treatment and prevention of HIV. It is one of the most common HIV ARVs used around the world.
Emtricitabine (Emtriva) is a nucleoside reverse transcriptase inhibitor (NRTI). It inserts itself into the virus' DNA by pretending to be a DNA building block, but actually stops the DNA making process. When this happens the HIV virus can't make copies of itself.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Emtricitabine (Emtriva) is one of the two HIV ARVs in Truvada and Descovy. The two HIV ARV combos used for the prevention of HIV, also known as pre-exposure prophylaxis or PrEP. However, only the HIV ARV combination tablets are FDA approved to be used for PrEP.
You may see that some people open their capsules of emtricitabine (Emtriva) and mix the contents with water. However, the manufacturer does not provide data or directions for doing so. Since the medication comes as an oral solution that has been well studied, it's best to talk to your healthcare provider about your options if you are having a hard time swallowing the capsule.
There's no one right time to take emtricitabine (Emtriva). The most important thing is that you choose a time that you can take the medication at the same time everyday. Many people living with HIV find it helpful to take all their HIV ARVs at the same time.
If you forget your dose of emtricitabine (Emtriva), take it as soon as you remember unless it's almost time for your next scheduled dose. Never double up on doses.
Changes in weight are not common with emtricitabine (Emtriva), or any of the other NRTIs.
Emtricitabine (Emtriva) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
People who have stopped taking emtricitabine (Emtriva) have had severe worsening of their hepatitis B. Before you start emtricitabine (Emtriva) your provider will check if you have hepatitis B. If you do, your provider might start you on an anti-hepatitis B medication. Don't stop taking emtricitabine (Emtriva) unless instructed by your healthcare provider.
HIV attacks your immune system. Over time, if the virus isn't treated your body may become defenseless against bacterial and fungal infections. Your HIV medications are very good at killing the virus, and when the number of viruses goes down, your immune system gets started making more cells. Once your immune system gets better, it will start to fight off any infections you might have, which can lead to a lot of inflammation. Even though it's a good thing that your immune system is getting better, too much inflammation can be bad. Your healthcare provider might check for underlying infections (sometimes called opportunistic infections) before starting emtricitabine (Emtriva) especially if it is your first time taking HIV medications. Call your provider if you experience fever, difficulty breathing, or sudden changes to your health after starting emtricitabine (Emtriva).
Although rare, NRTIs including emtricitabine (Emtriva) can cause a life-threatening liver problem called lactic acidosis with hepatic steatosis. Most of the cases have been in women. Symptoms can include appetite loss, stomach pain, muscle pain, fast and shallow breathing, extreme tiredness, and sudden weakness. Stop taking emtricitabine (Emtriva) and go to the emergency room right away if this happens.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 200mg of | 30 capsules | $154.24 | $5.14 |
Adults:
Children: The dose is based on the child's age, weight, and whether they are taking the capsule or the oral solution